Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 14, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 12
- −1 vs. Q4 2024
- Portfolio value
- $164.3M
- −$93.8M (−36.3%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | Stock | 2,308,190 | $65.4M | 39.8% | 00.0% | Unchanged | History |
| PSNLPersonalis, Inc. | COM | 14,044,943 | $49.3M | 30.0% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $21.1M | 12.9% | 00.0% | Unchanged | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $15.7M | 9.6% | 00.0% | Unchanged | – |
| ALECAlector, Inc. | COM | 3,545,719 | $4.36M | 2.7% | 00.0% | Unchanged | History |
| EVAXEvaxion A/S | COM | 1,214,126 | $2.25M | 1.4% | +671,847+123.9% | Added | History |
| STROSutro Biopharma, Inc. | COM | 2,723,509 | $1.77M | 1.1% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 1,149,345 | $1.46M | 0.9% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $1.26M | 0.8% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 1,483,758 | $1.07M | 0.7% | 00.0% | Unchanged | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $456.7K | 0.3% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $57.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (1)
Positions held at the end of Q4 2024 that are gone from this filing.